Bayer stops blood thinner drug trial for lack of effect in major setback, World News - AsiaOne

Germany's Bayer has aborted a large late-stage trial testing a new anti-clotting drug for lack of efficacy, dealing a fresh blow to the embattled drugmaker and throwing its most promising medium-term development project in doubt. It said in a statement late on Sunday that experimental anticoagulant asundexian, which it had hoped would generate annual sales of more than 5 billion

WHO says monkeypox containable, convening research meeting to support member states, World News - AsiaOne

Official Global Release of the New Mobile Puzzle Game 'Pucca Puzzle Adventure' on January 26, Business News - AsiaOne

WHO urges countries 'not to lose gains' by prematurely lifting Covid-19 measures, World News - AsiaOne

Taliban stopped 100 women flying to Dubai for university scholarships, UAE billionaire says, Asia News - AsiaOne

Digitrio promises to deliver Faster, Better SEO using the Pareto Principle, Business News - AsiaOne

Bayer woes pile up as blood thinner drug trial fails

UN warns 'time is running out' as greenhouse gases surge, World News - AsiaOne

Popular blood thinner associated with higher risk of bleeding complications - Medical Update Online

Too big to fail: 4 insurers to face higher standards and scrutiny under new MAS rule, Money News - AsiaOne

Blood Thinners Recalled Over Cancer-Causing Impurity

Biden not surprised by report of Wagner boss Yevgeny Prigozhin's death, World News - AsiaOne

Bayer Stops Blood Thinner Drug Trial Due To Lack Of Effect, In Major Setback • GABI

MUSEUM OF BROADWAY OPENS NEW SPECIAL EXHIBIT CELEBRATING CHICAGO, Business News - AsiaOne

A new winter-themed Minecraft world for learning English arrives, Business News - AsiaOne